272 related articles for article (PubMed ID: 23623990)
41. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
42. Inhibiting thrombin improves motor function and decreases oxidative stress in the LRRK2 transgenic Drosophila melanogaster model of Parkinson's disease.
Johnson SL; Iannucci J; Seeram NP; Grammas P
Biochem Biophys Res Commun; 2020 Jun; 527(2):532-538. PubMed ID: 32423817
[TBL] [Abstract][Full Text] [Related]
43. Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson's disease.
Quintero-Espinosa D; Jimenez-Del-Rio M; Velez-Pardo C
Brain Res; 2017 Feb; 1657():253-261. PubMed ID: 28041945
[TBL] [Abstract][Full Text] [Related]
44. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Thakur P; Nehru B
Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
[TBL] [Abstract][Full Text] [Related]
45. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
46. Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells.
Silva LG; Ferguson BS; Avila AS; Faciola AP
J Anim Sci; 2018 Dec; 96(12):5244-5252. PubMed ID: 30252114
[TBL] [Abstract][Full Text] [Related]
47. Neuroprotective Effects of a Standardized Flavonoid Extract from Safflower against a Rotenone-Induced Rat Model of Parkinson's Disease.
Ablat N; Lv D; Ren R; Xiaokaiti Y; Ma X; Zhao X; Sun Y; Lei H; Xu J; Ma Y; Qi X; Ye M; Xu F; Han H; Pu X
Molecules; 2016 Aug; 21(9):. PubMed ID: 27563865
[TBL] [Abstract][Full Text] [Related]
48. Mutation in Drosophila methuselah resists paraquat induced Parkinson-like phenotypes.
Shukla AK; Pragya P; Chaouhan HS; Patel DK; Abdin MZ; Kar Chowdhuri D
Neurobiol Aging; 2014 Oct; 35(10):2419.e1-2419.e16. PubMed ID: 24819147
[TBL] [Abstract][Full Text] [Related]
49. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
[TBL] [Abstract][Full Text] [Related]
50. The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia.
Jaworska J; Ziemka-Nalecz M; Sypecka J; Zalewska T
J Neuroinflammation; 2017 Feb; 14(1):34. PubMed ID: 28187734
[TBL] [Abstract][Full Text] [Related]
51. Rotenone induces non-specific central nervous system and systemic toxicity.
Lapointe N; St-Hilaire M; Martinoli MG; Blanchet J; Gould P; Rouillard C; Cicchetti F
FASEB J; 2004 Apr; 18(6):717-9. PubMed ID: 14766796
[TBL] [Abstract][Full Text] [Related]
52. The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings.
von Wrangel C; Schwabe K; John N; Krauss JK; Alam M
Behav Brain Res; 2015 Feb; 279():52-61. PubMed ID: 25446762
[TBL] [Abstract][Full Text] [Related]
53. Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug platform.
Chiu S; Terpstra KJ; Bureau Y; Hou J; Raheb H; Cernvosky Z; Badmeav V; Copen J; Husni M; Woodbury-Farina M
J Complement Integr Med; 2013 Nov; 10():. PubMed ID: 24200537
[TBL] [Abstract][Full Text] [Related]
54. Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania.
Stertz L; Fries GR; Aguiar BW; Pfaffenseller B; Valvassori SS; Gubert C; Ferreira CL; Moretti M; Ceresér KM; Kauer-Sant'Anna M
Braz J Psychiatry; 2014; 36(1):39-46. PubMed ID: 24346357
[TBL] [Abstract][Full Text] [Related]
55. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
56. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
Sherer TB; Kim JH; Betarbet R; Greenamyre JT
Exp Neurol; 2003 Jan; 179(1):9-16. PubMed ID: 12504863
[TBL] [Abstract][Full Text] [Related]
57. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
Lin CH; Huang JY; Ching CH; Chuang JI
J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
[TBL] [Abstract][Full Text] [Related]
58. Modulatory effect of Decalepis hamiltonii on ethanol-induced toxicity in transgenic Drosophila model of Parkinson's disease.
Jahromi SR; Haddadi M; Shivanandappa T; Ramesh SR
Neurochem Int; 2015 Jan; 80():1-6. PubMed ID: 25451756
[TBL] [Abstract][Full Text] [Related]
59. The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments.
Ravenstijn PG; Merlini M; Hameetman M; Murray TK; Ward MA; Lewis H; Ball G; Mottart C; de Ville de Goyet C; Lemarchand T; van Belle K; O'Neill MJ; Danhof M; de Lange EC
J Pharmacol Toxicol Methods; 2008; 57(2):114-30. PubMed ID: 18155613
[TBL] [Abstract][Full Text] [Related]
60. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats.
Alam M; Schmidt WJ
Behav Brain Res; 2002 Oct; 136(1):317-24. PubMed ID: 12385818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
